Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
22.19
+0.31 (1.42%)
At close: Oct 15, 2026, 4:00 PM EDT
22.30
+0.11 (0.50%)
Pre-market: Oct 16, 2026, 4:01 AM EDT
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $1.58 billion as of October 15, 2026. It is the 7,756th most valuable company in the world and the 1,946th biggest in the United States. Its market cap has decreased by 8.82% in one year.
Market Cap
1.58B
Enterprise Value
245.94M
1-Year Change
-8.82%
Global Rank
Country Rank
#1,946 United States
Category
ChartMarket Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $1.58B, an increase of 188.32%. That is a compound annual growth rate of 33.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 1.58B | -67.09% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Septerna | 1.70B |
| Maravai LifeSciences Holdings | 1.70B |
| Intellia Therapeutics | 1.67B |
| Nuvation Bio | 1.66B |
| Zenas BioPharma | 1.64B |
| Ocular Therapeutix | 1.59B |
| Braveheart Bio | 1.58B |
| Generate Biomedicines | 1.57B |